These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9281205)

  • 21. [Genetic aspects of atherogenic dyslipoproteinemias].
    de Gennes JL
    Ann Biol Clin (Paris); 1986; 44(5):556-8. PubMed ID: 3813140
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The genetic contribution to coronary disease. The genetic factors related to lipid metabolism].
    da Silva PM
    Rev Port Cardiol; 1999; 18(7-8):735-47. PubMed ID: 10466375
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of the denaturing gradient gel electrophoresis (DGGE) method for mutational screening of patients with familial hypercholesterolaemia (FH) and Familial defective apolipoprotein B100 (FDB).
    Azian M; Hapizah MN; Khalid BA; Khalid Y; Rosli A; Jamal R
    Malays J Pathol; 2006 Jun; 28(1):7-15. PubMed ID: 17694954
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Genetic predisposition for the multiple metabolic syndrome. Part 4. Apolipoprotein E and lipoprotein (a)].
    Sobra J; Ceska R
    Cas Lek Cesk; 1999 Mar; 138(7):203-8. PubMed ID: 10510535
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Common genetic variants that relate to disorders of lipid transport in Spanish subjects with premature coronary artery disease.
    Masana L; Febrer G; Cavanna J; Baroni MG; Marz W; Hoffmann MM; Shine B; Galton DJ
    Clin Sci (Lond); 2001 Feb; 100(2):183-90. PubMed ID: 11171287
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetics and metabolism of lipoprotein(a) and their clinical implications (Part 1).
    Dieplinger H; Kronenberg F
    Wien Klin Wochenschr; 1999 Jan; 111(1):5-20. PubMed ID: 10067265
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dietary, physiological, genetic and pathological influences on postprandial lipid metabolism.
    Lopez-Miranda J; Williams C; Lairon D
    Br J Nutr; 2007 Sep; 98(3):458-73. PubMed ID: 17705891
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The relationship between leptin and lipids in atherosclerosis.
    Tamer L; Ercan B; Unlü A; Sucu N; Pekdemir H; Eskandari G; Atik U
    Indian Heart J; 2002; 54(6):692-6. PubMed ID: 12674182
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of lipid levels, hyperlipidemia prevalence and its risk factors between Guangxi Hei Yi Zhuang and Han populations.
    Yin R; Chen Y; Pan S; He F; Liu T; Yang D; Wu J; Yao L; Lin W; Li R; Huang J
    Arch Med Res; 2006 Aug; 37(6):787-93. PubMed ID: 16824940
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Familial defective apolipoprotein B-100.
    Hansen PS
    Dan Med Bull; 1998 Sep; 45(4):370-82. PubMed ID: 9777289
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Apolipoprotein E and its alleles in healthy subjects and in atherosclerosis].
    Couderc R; Bailleul S
    Ann Biol Clin (Paris); 1998; 56(6):651-9. PubMed ID: 9853024
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic determinants of atherosclerosis-related dyslipidemias and their clinical implications.
    Galton DJ
    Clin Chim Acta; 1997 Jan; 257(2):181-97. PubMed ID: 9118562
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Molecular biology and biochemical study of hyperlipemia and atherosclerosis].
    Chen B
    Zhonghua Yi Xue Za Zhi; 1995 Oct; 75(10):579-80. PubMed ID: 8697068
    [No Abstract]   [Full Text] [Related]  

  • 34. [The role of genetic and external factors in the development of precursors of arteriosclerosis in children and adolescents].
    Kostiurina GN; Bogmat LF; Evseeva ZN; Tolmacheva SR
    Pediatriia; 1992; (4-6):76-7. PubMed ID: 1408582
    [No Abstract]   [Full Text] [Related]  

  • 35. Genetic lipid disorders in cardiovascular disease.
    Genest J
    Trends Cardiovasc Med; 1992; 2(4):140-5. PubMed ID: 21239260
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hyperlipidemia, dyslipoproteinemia and apolipoproteinopathia--classification and risk of atheroslcerosis. Part I: Principles of classification and methods of dyslipoproteinemia determination.
    Choluj B; Votruba T; Kormúth E
    Acta Univ Carol Med (Praha); 1991; 37(3-4):91-105. PubMed ID: 1845469
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Atherosclerosis and lipid disorders after renal transplantation.
    Drüeke TB; Abdulmassih Z; Lacour B; Bader C; Chevalier A; Kreis H
    Kidney Int Suppl; 1991 Apr; 31():S24-8. PubMed ID: 2046266
    [No Abstract]   [Full Text] [Related]  

  • 38. DNA, hyperlipidaemias and atherosclerosis.
    Kontula K; Aalto-Setälä K; Nikkilä E
    Ann Clin Res; 1986; 18(5-6):242-9. PubMed ID: 3551772
    [No Abstract]   [Full Text] [Related]  

  • 39. DNA polymorphisms of the apolipoprotein genes--their use in the investigation of the genetic component of hyperlipidaemia and atherosclerosis.
    Humphries SE
    Atherosclerosis; 1988 Aug; 72(2-3):89-108. PubMed ID: 3063270
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Progress in the study of lipoprotein metabolism and atherosclerosis: progress in the molecular genetic study of apolipoproteins and hyperlipidemia].
    Itoh H; Mabuchi H; Takeda R
    Nihon Rinsho; 1988 Mar; 46(3):644-51. PubMed ID: 2900342
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.